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Abstract
Stroke is a major global health problem whereby many survivors have unmet needs concerning mobility
during recovery. As such, the use of robotic assisted devices (i.e.,  a bionic leg) within a community-
setting may be an important adjunct to normal physiotherapy in chronic stroke survivors. This study will
be a dual-centre, randomized, parallel group clinical trial to investigate the impact of a community based,
training program using a bionic leg on biomechanical, cardiovascular and functional outcomes in stroke
survivors. Following a baseline assessment which will assess gait, postural sway, vascular health (blood
pressure, arterial stiffness) and functional outcomes (6-minute walk), participants will be randomized to a
10-week program group, incorporating either: i) physiotherapy plus community-based bionic leg training
program, ii) physiotherapy only, or iii) usual care control. The training program will involve participants
engaging in a minimum of 1 hour per day of bionic leg activities at home. Follow up assessment, identical
to baseline, will occur after 10-weeks, 3 and 12 months post intervention. Given the practical implications
of the study, the clinical significance of using the bionic leg will be assessed for each outcome variable.
The potential improvements in gait, balance, vascular health and functional status may have a meaningful
impact on patients’ quality of life. The integration of robotic devices within home-based rehabilitation
programs may prove to be a cost effective, practical and beneficial resource for stroke survivors.
Keywords: robotic assisted, stroke survivors, walking, gait, blood pressure
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Introduction
By 2030, stroke burden is expected to double, with increasing survival rates as medical care and
treatment  techniques  improve  (1).  This  leads  to  an  increasing  population  with  diverse  stroke-related
disabilities,  which may include limitations in communication, activities of daily living,  co-ordination,
balance and mobility (2). It is estimated that following a stroke only 15% of sufferers will gain complete
functional recovery for both the upper and lower extremities (3). As such, many stroke survivors continue
to have unmet needs, especially concerning mobility (4). Although some individuals with stroke will have
received some rehabilitation during the acute  and sub-acute  phases,  rarely does  rehabilitation extend
beyond one year post-injury due to a lack of resources for long term services (5).
Gait impairment, and therefore a reduction in functional ability, leads to many stroke survivors
becoming sedentary. Objective activity monitoring of stroke survivors has showed that >80% of time is
spent sedentary, independent of functional ability, and that in the first year post-stroke, there is minimal
behavior change (6). With this increased sedentary time, there is a concurrent reduction in fitness and an
increased risk of cardiovascular and all-cause mortality and morbidity (7).  A reduction in post-stroke
fitness  could  arise  from  the  accumulation  of  low  pre-stroke  physical  activity  and  fitness,  direct
neurological  effects  of  stroke  and  the  effect  of  post-stroke  physical  inactivity  (8).  For  many  stroke
survivors, improving walking ability and mobility is widely regarded to be an important rehabilitation
goal (9,10). 
Recent advances in medical technology have helped to develop robotic devices to aid gait training
in order to restore pre-stroke movement patterns and improve quality of gait for stroke survivors (11).
Robotic rehabilitation may help to promote limb function in stroke patients by stimulating neuroplasticity
(12) and has the potential to provide intensive, repetitive, and task-specific practice which could enhance
functional restitution and improve motor performances  (13). Although some robotic devices are large,
complex and cumbersome, which necessitates that the therapist be present during use (14), externally
wearable commercially available devices that can be independently used during home-based post-stroke
rehabilitation are available (15). The integration of robotic therapy into current practice could increase the
efﬁciency  and  effectiveness  of  therapists  by  alleviating  the  labor-intensive  aspects  of  physical
rehabilitation and by enabling  novel  modes of  exercise  not  currently available.  Robotic-assisted gait
training has been shown to exhibit significantly greater improvements in gait and balance, as measured by
the  functional  ambulation  capacity  scale,  when  compared  to  regular  physiotherapy  alone  (16).
Furthermore, with significant increases in physical activity, step count, and walking capacity observed
with the use of lower limb robotic devices (17), such applications may elicit important cardiovascular
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benefits  for  stroke  survivors  (8).  Increases  in  ambulatory  activity  has  been  shown  to  improve
cardiorespiratory fitness and reduce the risk of recurrent cardiovascular events (18).
Research into robotic devices has focused on the implementation within a clinical setting. As
patient access to such devices may be constrained by both the accessibility and availability, community-
based programs may be efficacious as patients could use such devices more frequently. Despite this, to
date, research into robotic devices within a community setting is limited for patients with stroke. Further,
studies either have small (n = 1) sample sizes (19), or are non-randomized control trials (20). Accordingly,
this study will investigate the acute and longer-term effects of using a lower limb robotic device in a
community setting on pertinent biomechanical (gait,  postural sway), vascular (blood pressure, arterial
stiffness) and functional (lower limb strength, 6-minute shuttle walk test) measures in chronic stroke
survivors.  It  is  hypothesized that  a 10-week community rehabilitation program with a robotic device
(bionic leg) will lead to greater changes in the aforementioned outcome measures compared to stroke
survivors receiving stand-alone physiotherapy or usual care. 
Methods
Research Design 
This is a dual-centre, randomized, parallel group clinical trial. Stroke survivors will be identified
from a  neuro-physiotherapy practice  and/or  community-based,  stroke  support  groups  (Figure  1).  All
participants will have been diagnosed with stroke by a specialist neurologist/stroke consultant from a UK
National  Health  Service  (NHS)  Foundation  Trust,  and  will  have  undertaken  normal  inpatient  and
outpatient  rehabilitation  in  accordance  with  NICE  guidelines  (21).  Participants  with  a  Functional
Ambulation Score of 2-5 (22), and who meet the following inclusion criteria are eligible to participate in
the study.
Inclusion criteria
 Patients with diagnosis of stroke within 3 months to 5 years of study start date.
 Community  patients  that  are  medically  stable  and are   either  i)  currently  receiving  physical
therapy from a neurophysiotherapy practice, or ii) attending a community-based, stroke support
group and do not actively receive physical therapy
 Individuals who are able to stand and step with an aid or with assistance. 
 Cognitively aware to undertake rehabilitation exercises, physical therapy and physical activity  
 Height: 1.58 to 1.92 m
 Weight: < 159 kg
4
Exclusion Criteria 
 Unresolved deep vein thrombosis, unstable cardiovascular conditions, open wounds, active drug
resistant  infection,  recent  fractures of involved limb, peripheral  arterial  disease,  incontinence,
severe osteoporosis, non-weight bearing.
Randomization
Web-based  randomization  procedures  will  be  prepared  by  an  investigator  with  no  clinical
involvement in the trial. Participants receiving physical therapy from the neurophysiotherapy practice will
be assigned to one of two groups:
i) a 10-week community-based, bionic leg plus normal physiotherapy program (BL)
ii) a 10-week normal physiotherapy program (NP)
A third group, recruited from community-based, stroke support groups, will also be assessed in the study:
iii) Usual care case control group [no physiotherapy program] (CON)
Covariate adaptive randomization is a valid randomization method for clinical research and will
be used to ensure balance between BL and NP (23). Covariate adaptive randomization uses the method of
minimization  by  assessing  the  imbalance  of  sample  size  between  several  covariates.  In  this  study,
participants will  be sequentially assigned to  BL or  NP by taking into account the following specific
covariates: i)  baseline postural sway (only able to stand with an aid vs. able to stand unaided; able to
stand ≤ 2 mins vs. able to stand > 2 mins), ii) systolic blood pressure (SBP > 160 vs. < 160 mmHg), iii)
age (age > 70 y vs. < 70 y), and iv) time since stroke (< 12 months vs. > 12 months). Allocation will be
undertaken by the principle investigator, who will not be involved in assessing patient outcomes. The
principal investigator will inform the participant of group allocation. Although participants and a research
assistant will be aware of the allocated treatment condition, outcome assessors and data analysts will be
kept blinded to the allocation, which will be concealed until the end of the study.
Baseline assessment and outcome measures
Participants will be fasted (> 10 hours), refrain from caffeine consumption for > 12 hours and will
not  have  undertaken  moderate-to-strenuous  physical  activity  for  >  24  hours  prior  to  the  baseline
laboratory assessment. Primary and secondary outcome measures will be monitored during the baseline
assessment (Figure 1, Table 1).  These measures include biomechanical  (gait  analysis,  postural sway),
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cardiovascular  (central  and  peripheral  blood  pressures,  arterial  stiffness  of  the  carotid  artery,  blood
velocity of the carotid artery) and functional (aerobic fitness, strength) tests. Cardiovascular measures will
be completed first, in a supine position, following 20 minutes of supine rest (Figure 2). Biomechanical
measures will be recorded whilst standing, and during walking-based movement assessments. Functional
measures will be undertaken in both supine and upright seated positions (lower-limb strength tests) and
during a physical ambulatory test (aerobic fitness test). On completion of the baseline health assessment
participants will  also complete a series of questionnaires including the International Physical Activity
Questionnaire  (IPAQ),  Older  People’s  Quality  of  Life  Questionnaire,  Functional  Ambulation
Classification, Dynamic Gait Index, Berg Balance Scale and Trail  Making Test (Table 1).  Follow up
assessments of all primary and secondary assessments will occur at 10-weeks post intervention, 3 and 12
months post. 
On completion of the baseline assessment participants will be randomized to either BL or NP, if
identified from a neuro-physiotherapy practice, or will be identified from a local stroke support group and
will  contribute  to  the  usual  care  control  group.  Participants  will  also  wear  an  ActivPal  (Glasgow,
Scotland) to assess daily physical activity. The monitor will be secured onto the mid rectus femoris for a
period  of  7  days  following  the  baseline  assessment,  at  5  weeks  mid-intervention,  10-weeks  post
intervention, 3 and 12 months follow-up. 
Bionic leg group (BL)
Participants randomized to the BL group will receive a bionic leg (Alter-G, Fremont, CA, USA)
to take home for the duration of the study. Participants will  be required to wear the bionic leg for a
minimum of 1 hour per day, for a period of 10-weeks. Although recorded, no daily maximum wear-time
will be imposed on participants. Settings for the bionic leg will be individualized for each participant,
consisting of weight,  assistance,  resistance,  threshold and knee extension angle settings.  Participants’
progress with the bionic leg will be checked at weeks 2, 4, 6, and 8 by a research assistant. The assistance
and threshold settings will be altered in an attempt to elicit progressive overload. Assistance refers to the
amount of support the device provides to the participant to help with extension of the lower extremity.
This is an approximate percentage of the individual’s single-limb bodyweight, whereby a higher value
demonstrates a greater contribution from the bionic leg. Threshold refers to the percentage of overall body
weight that is necessary through the participant’s foot to activate the device’s footplate before it will
provide assistance. A lower value activates the device with less weight and is therefore more sensitive to
small weight shifts making it easier for the participant. Participants will also be provided with a physical
activity diary whereby the number of steps, duration of use and activities undertaken while using the
bionic leg are recorded daily. During this time, participants will also undertake their regular rehabilitation
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therapy at their physiotherapy practice. 
Normal physiotherapy group (NP)
Participants  will  undertake  their  regular  rehabilitation  therapy  at  their  local  physiotherapy
practice. Participants will also be advised to engage in a minimum of 1 hour of physical activity each day
for the duration of the 10 week intervention. 
Usual care case control group (CON)
Participants will be advised to engage in a minimum of 1 hour of physical activity each day for
the duration of the 10-week intervention. These participants will not attend any rehabilitation sessions for
the period of the intervention.
Participants in both NP and CON will keep a record of their daily activity recording their total
time active, and type of activities undertaken.
Ethical approval and informed consent
The study protocol has received institutional ethical approval. The study has also been registered
with the Clinical Trials.gov Protocol Registration and Results System (NCT03104127). Written informed
consent will be obtained from all participants prior to the commencement of the study. 
Data monitoring body
A research  steering  committee  will  meet  once  every  3  months  to  discuss  data  and  safety
monitoring (i.e., adverse events) and to provide advice on implementation of the research outcomes and
outputs. The steering committee will include members of the research team and external stakeholders
from the university sector, rehabilitation practice and community.
Sample size
Forty-five participants will be recruited and evenly allocated to each of the three groups (BL, NP or CON)
to enable an appropriate sample size to be calculated for a larger trial.  
Data analysis
Baseline  characteristics  of  the  three  study  groups  will  be  described  by  means  and  standard
deviations and percentages as appropriate for the level  of measurement and distributions of the data.
Baseline characteristics will be compared between groups using a series of one-way analysis of variance
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(ANOVA). With the inclusion of the previously identified covariates (baseline postural sway,  systolic
blood pressure, age, time since stroke), a series of two-way repeated measures analysis of covariance:
Condition (BL, NP, CON) by Time (baseline, post-intervention, 3 & 12 month follow-up), will be used to
compare all primary and secondary outcome measures. Where statistical differences are observed from
the  preceding  analyses,  post-hoc  analyses  for  multiple  comparisons  will  be  conducted  (Bonferroni
adjusted t-tests; Tukeys HSD). An intention-to-treat analysis will be used on all consented participants
who  are  unable  to  attend  the  follow-up  assessment.  Effect  sizes  will  be  reported  to  describe  the
importance of the relevant findings in practical terms using partial eta squared (ηp2), with 0.0099, 0.0588,
and 0.1379 representing a small, medium, and large effect (24).
Discussion 
With the worldwide burden of stroke expected to continue to rise, there is an ever increasing need
to provide efficacious medical and rehabilitation treatment strategies. This is of great importance when
considering that only a small proportion of stroke survivors regain complete functional recovery in the
years  following their  stroke  diagnosis  (3).  With  stroke  survivors  often  experiencing  difficulties  with
walking, balance and mobility  (9,10), lower-limb robotic devices, such as the bionic leg, may provide
stroke survivors with the opportunity to improve everyday functional movements. Furthermore, as such
devices may elicit an increase in physical activity by increasing the number of steps taken each day, there
may be important cardiovascular and quality of life benefits for stroke survivors who engage with such
technology during their rehabilitation as it may reduce the risk of future cardio- or cerebrovascular events.
With physical therapists often using manual therapeutic approaches to improve upper and lower limb
function during face-to-face rehabilitation sessions, the integration of robotic devices within home-based
rehabilitation programs may elicit greater improvements in stroke survivors functional health (2,15).  Due
to the increasing emphasis on moving stroke rehabilitation resources to community-based settings (25),
and  the  overall  lack  of  community-based  stroke-rehabilitation  research  (26,27),  there  is  a  need  to
undertake randomized controlled trials within the community setting to evaluate the importance of using
robotic devices.  
This study will significantly contribute to our knowledge in using lower-limb robotic devices in a
community-based setting for patients with stroke. The potential improvements in gait, walking speed and
balance may have a meaningful impact on patients’ everyday quality of life. As such, the use of a bionic
leg within a community-setting may be an important adjunct to normal physiotherapy in chronic stroke
survivors. The study will provide much needed data for stroke patients concerning the biomechanical and
physiological  effects of  training programs incorporating robotic assistive devices.  Given the practical
implications  of  the  study,  the  clinical  significance  of  utilising  the  bionic  leg  in  a  10-week  training
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program will be assessed for each outcome variable, over both the short- (baseline to post-intervention)
and longer-term (3 and 12 month post).
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Table Legend:
Table 1 Study outcomes to be measured at baseline, post-intervention, 3-months, and 12-months follow
up
Figure Legends:
Figure 1 Study protocol
Figure 2 Assessment procedure for baseline, post-intervention, 3 and 12 month follow-up
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Table 1 Study outcomes to be measured at baseline, post-intervention, 3-months, and 12-months follow up
Dependent variable Procedure / measures Study outcome Type of measurement
BIOMECHANICAL
Gait analysis Eight Qualisys cameras (six Oqus 3+, two Oqus 5+, Goteborg, Sweden) will be used to
measure  joint  angles,  rotations,  hip  obliquity,  segment  accelerations  and  velocities.  Six
Degrees  or  Fredom 6DoF 27 point  marker set  will  be  used and joint  centres  identified
through palpation. The participants will be asked to walk for 6 meters, over a pressure mat
(RSscan Footscan, Ipswitch, UK), for minimum of three trials in order to obtain walking gait
patterns. A BTS G-Walk (Brooklyn, New York) sensor will also be worn by the participants
to  collect  additional  spatio-temporal  gait  parameters  (cadence,  speed,  stride/step  length,
stance/swing phase duration, single/double support duration and pelvic girdle angles).
Primary Movement Assessment
Postural sway Postural  sway  parameters  of  maximal  anterior-posterior  and  medio-lateral  sway will  be
calculated on the basis of centre of pressure. Time series will be acquired by means of a
pressure mat mounted on top of a Kistler force platform (Kistler, Winterthur, Swizerland).
Participants will stand on the pressure mat, unaided if possible, and trials will consist of eyes
open shoes on, eyes closed shoes on, eyes open shoes off, eyes closed shoes off. A minimum
of three trials will be performed for each condition, each lasting 10s. 
Primary Balance
Ashworth scale An adapted Modified Ashworth Scale will  be used to  assess  muscle function. This  will
include  the  assessment  of;  Hip  flexion,  extension,  abduction,  adduction;  Knee  flexion,
extension; Ankle dorsiflexion, plantar flexion. Each movement will be graded from 0-5.
Secondary Resistance
PHYSIOLOGICAL
Health History Questionnaire Questionnaire to  identify  family  history,  personal  history  and  signs  and  symptoms  of
cardiovascular disease, and to provide a lifestyle evaluation
Secondary Rest
Body mass Body weight, body mass index      Secondary Rest
Central  and  peripheral  blood
pressures
Pulse wave analysis (PWA) will investigate central blood pressures, augmentation index and
arterial stiffness following 20 minutes supine rest. Pulse wave velocity (PWV) will also be
recorded between the carotid (right and left) and femoral artery, and between the anterior
tibial artery (right and left) and femoral artery
     Secondary Rest
Arterial stiffness of carotid artery Following 20 minutes supine rest, local arterial stiffness of the right and left carotid arteries Secondary Rest
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will be imaged 1-2 cm proximal to the bifurcation using B-mode ultrasound. 
Blood velocity of carotid artery
FUNCTIONAL
Doppler ultrasonography will be used to calculate bilaterally volumetric blood flow in the
carotid artery.  Blood flow will  be recorded using a Doppler  spectral  trace for  1 minute
during supine rest.
Secondary Rest
Physical fitness A 6-minute shuttle walk test will determine total distance walked. Participants’ perception of
exertion will be measured at 2, 4 and 6 minutes. 
Secondary Physical activity
Timed up-and-go A BTS  G-walk  system  will  be  used  to  collect  Timed-Up-and-Go  data.  From  a  seated
position, participants will stand, walk to a cone 3 m away, walk around the cone, and walk
back to the chair sit back down. Participants will complete two familiarisation trials prior to
the actual test itself. A minimum of three trials will be performed.
Secondary Physical activity
Strength
7-day physical activity
QUESTIONNAIRES
Dynamic gait index
Berg Balance
Lower Limb muscle strength will be assessed using a Lafayette hand held dynamometer
(Lafayette, USA). Measures will include; Hip abduction, adduction, flexion; Knee flexion,
extension; Ankle dorsiflexion, plantar flexion. Participants will be on a massage bed and
perform up to three maximal trials for each measure with a minimum of one minutes rest
between each measure.
An ActivPal physical activity monitor will be used for 7 days at baseline, 5 weeks into the
intervention, and on completion of the 10 week intervention to assess participants’ daily
physical activity. Measures include; time seated, time standing, ambulation, number of steps,
number of sit to stands, and energy expenditure.
8-item test that assesses dynamic balance and gait ability. Scored by rating the participants’
performance; walking on a level surface, changing speed while walking, turning the head
from side to side and up and down while walking, sudden turns, obstacle negotiation, and
stair negotiation. The dynamic gate index has excellent reliability (ICC > 0.94) (28) and
validity (r = 0.83) (29). 
14-item  test  that  assesses  static  and  dynamic  balance  ability  and  fall  risk  in  adult
populations.  Each  activity  is  scored  from 0-4,  determined by the  ability  to  perform the
assessed  activity  with  an  overall  maximum  score  of  56.  The  Berg  Balance  scale  has
Secondary
Secondary
Secondary
Resistance
Physical activity
Physiotherapist assessment
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Balance Confidence Scale
Walking Ability Questionnaire
Functional Ambulation 
Classification
IPAQ
Older Peoples Quality of Life 
Questionnaire
Trail Making 
Stroop task
excellent reliability (ICC > 0.95) and strong correlations with the Fugl-Meyer and Postural
Assessment Scale for Stroke patients (r > 0.90) (30).
16-item self-report measure in which patients rate their balance confidence when performing
various  ambulatory  activities.  Rated  from  0-100.  This  scale  has  excellent  test-retest
reliability (ICC = 0.85) within the Stroke population (31).
19-item questionnaire to assess the participant’s social limitations resulting from decreased
walking ability.  Mobility is classified as independent,  supervised, assisted, wheelchair or
unable for 19 ambulatory activities commonly performed in the home and community.
Assesses functional ambulation in participants undergoing physical therapy. Ranges from
non-functional walking to independent walking outside with a scale for 0-5 respectively. The
Functional Ambulation Classification has excellent validity with the 6 minute walking test in
acute Stroke patients (32).
Collects information on the time spent (number of days and average time per day) spent
being physically active (33).
36-item questionnaire that assesses quality of life. Each question is rated from 0-5 from very
bad to very good respectively. The OPQLQ has excellent test-retest reliability (ICC = 0.92)
(34)
A neuropsychological  test  of  visual  attention  and  task  switching.  Consists  of  two tests,
including: i) a test in which the participant is instructed to connect 25 numerical dots in
order,  and  ii)  a  test  in  which  the  participant  is  instructed  to  connect  25  numerical  and
alphabetical dots in order.
Is a measure of prefrontal cortex function (35)
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# Identical to the baseline assessment
Figure 1 Study protocol 
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Stroke Diagnosis
Attends neuro-physiotherapy practice and
receives weekly physiotherapy / Attends stroke
support group but does not receive
physiotherapy
Patient Screening: Inclusion criteria met Excluded from research studyNo
Informed Consent provided No
Baseline Assessment (Table 1/Figure 2)
Attends stroke support group
but does not receive
physiotherapy (Control)
NoAttends neuro-physiotherapy practice and
receives weekly physiotherapy
Yes
*Participants in the Bionic leg group
will have the settings of the device
checked at weeks 2, 4, 6 and 8 to
ensure progressive overload
Randomization to either Bionic Leg* or Normal
Therapy
10 week Post-intervention Assessment #
3 Month Follow-up Assessment #
12 Month Follow-up Assessment #
         
Abbreviations: BP = Blood pressure, CA = Carotid artery
Figure 2 Assessment procedure for baseline, post-intervention, 3 and 12 month follow-up
18
FunctionalBiomechanicalPhysiological
Tests
6-minute walk test
Timed up and go
Strength measures
Gait Analysis
Postural sway
Ashworth Scale
Central & peripheral BP
Arterial stiffness of CA
Blood velocity of CA
Health History
Questionnaire
Body Composition
7-Day
ActivPal Outcome Measures
Time 30 minutes60 minutes20 minutes20 Minutes
Participants to attend
physiotherapy practice
within 7 days of baseline
tests for Questionnaires
with a physiotherapist
Other Information
20 minutes supine rest
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